Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
Yuwei Bai,1,2 Xiaoyun Wang,1,2 Bei Wang1,2 1Institute of Integration of Traditional Chinese and Western Medicine, The Hospital Affiliated to Jiangnan University, Wuxi, People’s Republic of China; 2Wuxi School of Medicine, Jiangnan University, Wuxi, People’s Republic of ChinaCorrespondence: Bei Wang,...
Saved in:
Main Authors: | Bai Y, Wang X, Wang B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/pan-cancer-analysis-of-the-prognostic-and-immunotherapeutic-value-of-p-peer-reviewed-fulltext-article-ITT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target
by: Cong Xiao, et al.
Published: (2024-12-01) -
Comprehensive analysis of the prognostic, immunological, and diagnostic roles of SIRT1 in pan-cancer and its validation in KIRC
by: Qi Liu, et al.
Published: (2025-01-01) -
Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
by: Nie Zhang, et al.
Published: (2025-01-01) -
Comprehensive multi-omics analysis showed that CDC6 is a potential prognostic and immunotherapy biomarker for multiple cancer types including HCC
by: Chenxuan Li, et al.
Published: (2025-03-01) -
Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01)